Adhera Therapeutics, Inc. company info

CIK 737207
IRS Number 112658569
State of incorporation DE
Business address P.O. BOX 2161
Mail address P.O. BOX 2161

Short summary

Adhera Therapeutics, Inc. is a North Carolina company, with head office located at P.O. Box 2161 Wake Forest, North Carolina 27588. In 2019 the company owned a total of 4.14 million USD worth of assets, including 3.58 million USD worth of current assets and 558.00 thousand USD worth of non-current assets. 2010 was the year when the company amassed the most assets.

Adhera Therapeutics, Inc. Income Statement

Name [in Millions USD]2007200820092010201120122013201420152016201720182019Trends
Revenue, Net 14.732.462.24
Cost of Goods and Services Sold 0.46
Gross Profit -0.38
Selling, General and Administrative Expense 10.0910.368.375.25
Research and development 14.8818.1111.445.170.720.690.320.110.910.24
Operating Expenses 25.4331.9937.2312.102.484.021.110.766.0915.41
Operating Income (Loss) -10.69-29.53-35.00-7.88-0.37-3.52-1.11-0.76-6.09-15.79
Investment Income, Interest and Dividend 0.010.24
Income Tax Expense (Benefit) 01.140.04-
Net income -8.05-27.75-29.42-9.55-1.57-6.48-1.11-0.84-6.22-16.75

Adhera Therapeutics, Inc. Balance Sheet

Name [in Millions USD]2007200820092010201120122013201420152016201720182019Trends
Cash and cash equivalents
Accounts Receivable, Net, Current 0.210.0100.010.090.09
Property, Plant and Equipment, Gross 11.68
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 8.749.25
Goodwill 3.503.50
Intangible Assets, Net (Excluding Goodwill) 22.736.706.706.706.706.702.732.310.360.34
Other Assets, Noncurrent
Total assets 7.2332.2010.196.8611.107.557.156.6314.472.764.14
Current assets 2.666.431.590.164.400.810.450.408.652.153.58
Non-current assets 6.235.820.600.56
Accounts payable 2.112.613.541.581.050.501.330.941.130.960.88
Taxes Payable, Current 0.450.10
Total current liabilities 5.136.916.405.582.
Long-term Debt 1.391.20
Deferred income taxes 1.202.352.382.352.352.352.35
Total liabilities 14.1215.8912.0411.0614.4310.056.072.705.279.52
Common Stock, Value, Issued 307.94322.09323.340.
Retained Earnings (Accumulated Deficit) -112.10-263.02-298.02-323.94-328.37-336.47-336.47-334.03-4.21-14.31-31.92-34.87

Adhera Therapeutics, Inc. Cash Flow

Name [in Millions USD]2007200820092010201120122013201420152016201720182019Trends
Net income -8.05-27.75-29.42-9.55-1.57-6.48-1.11-0.84-6.22-16.75
Depreciation 0.00
Amortization of Intangible Assets 0.050.450.33
Depreciation and amortization 2.371.581.250.56
Deferred Income Tax Expense (Benefit) 1.140.04-0.04
Accounts receivable 0.18-0.15-0.060.01-0.000.50-0.500.12
Inventories 0.20
Accounts payable 0.641.64-0.670.490.01-0.560.01-0.880.43-0.70
Deferred revenue -0.720.030.81-0.73-0.12
Net Cash Provided by (Used in) Operating Activities -7.53-16.80-16.12-0.74-0.52-1.26-9.61
Payments to Acquire Property, Plant, and Equipment 0.090.400.00
Payments to Acquire Businesses, Net of Cash Acquired -0.01
Payments to Acquire Intangible Assets 0.38
Net Cash Provided by (Used in) Investing Activities 2.344.640.000.01-0.38-0.07
Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 2.720.03
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 2.720.03
Proceeds from Issuance of Common Stock 10.25
Payments for Repurchase of Common Stock 0.25
Net Cash Provided by (Used in) Financing Activities 4.8512.4816.0210.361.6413.50
Cash and Cash Equivalents, Period Increase (Decrease) -0.340.32-0.09